Testosterone Propionate + Winstrol Cycle Kit by Dragon Pharma – Short-Ester Injectable Paired With an Oral Agent
Combining an injectable base with an oral compound creates two distinct administration channels, each demanding its own documentation trail and timing logic. The Test Prop + Winstrol Cycle Kit reflects that complexity: it pairs a short-ester testosterone preparation with an oral agent and the recovery material needed to close a gonadotropin-suppression study. Dragon Pharma supplies four vials of Proprionat 100, one pack of Winstrol 50 mg tablets, and one pack of Clomid, quantities matched precisely to the published schedule below. Because overlapping phases mean two compounds run concurrently during weeks five through ten, attribution of individual effects requires careful endpoint separation; consequently, sourcing from a supplier that publishes lot-level certificates of analysis protects both your budget and your data integrity. Before ordering, review our About Us page to understand how we source, manufacture, and ship every compound in this bundle.
What Is Included in the Kit?
This bundle contains three distinct research products, quantified so supply aligns with the full protocol window without mid-cycle reorder delays:
- Proprionat 100 — 4 vials, 10 ml each at 100 mg/ml testosterone propionate (4,000 mg / 40 ml total).
- Winstrol 50 — 1 pack of 100 tablets at 50 mg stanozolol per tablet (5,000 mg total).
- Clomid — 1 pack of 100 tablets for the recovery phase.
Investigators comparing individual components before committing to the bundle can browse each product separately on our home page.
Compound Profiles
Proprionat 100 delivers testosterone propionate suspended in an injectable oil base at 100 mg per millilitre. The propionate ester releases far more rapidly than longer chains such as enanthate or cypionate, producing a substantially shorter half-life that rewards frequent, evenly spaced administrations rather than weekly injections. Laboratories select this format when studies require tight temporal resolution around a defined observation window, since concentration curves respond visibly within days instead of weeks. At 100 mg/ml, one millilitre corresponds exactly to the 100 mg figure shown in the table, which simplifies volumetric calculation and reduces arithmetic errors during draw-up.
Winstrol 50 contains stanozolol, a dihydrotestosterone-derived oral agent modified at the C17 position with a pyrazole ring. That structural change permits oral bioavailability because the molecule resists rapid first-pass hepatic degradation, distinguishing it from injectable-only relatives. Researchers frequently pair stanozolol with a testosterone base because suppression of endogenous production accompanies use of either agent alone.
Clomid contains clomiphene citrate, a triphenylethylene selective estrogen receptor modulator widely used as the recovery agent in suppression protocols because it stimulates gonadotropin release.
Cycle Protocol Reference Table
The quantities above correspond directly to the following schedule. Please treat these figures as documentation of the supplied amounts, not as administration instructions.
| Phase | Duration | Compound | Protocol |
|---|---|---|---|
| Cycle | Weeks 1–10 | Testosterone Propionate (Proprionat 100) | 100 mg every other day (100 mg = 1 mL) |
| Cycle | Weeks 5–10 | Winstrol (Oral) | 50 mg every other day |
| PCT – Day 1 | Week 11 | Clomid | 150 mg |
| PCT – Day 2 | Week 11 | Clomid | 100 mg |
| PCT | Days 3–28 | Clomid | 50 mg/day |
How the Quantities Map to the Schedule
An every-other-day cadence across ten weeks produces roughly 35 administrations of testosterone propionate. At 1 ml per dose, that consumes about 35 ml against the 40 ml supplied, leaving approximately 5 ml of headroom once you account for draw-up losses and dead-space remaining in each vial. Meanwhile, the Winstrol allocation supports the six-week overlap block, and the Clomid pack covers the loading days plus the extended maintenance window described above. Verifying these calculations against your own records prevents mid-protocol shortages.
Handling and Injection-Schedule Guidance
Qualified personnel develop all handling procedures based on species, route, and experimental endpoint. Typically, technicians warm oil-based vials between the hands before drawing, since viscosity increases storage-related resistance. Unlike long-ester formats, the propionate ester clears quickly enough that spacing doses consistently matters more than total weekly volume; therefore, keep the every-other-day rhythm regular rather than clustering administrations. Note also that four separate containers simplify rotation: technicians can finish one vial completely before opening the next, reducing the number of punctured stoppers exposed to air. Oral units should stay sealed in their original blister packaging until use, with humidity control protecting tablet integrity. Once prepared, document each calculation step in your lab notebook so colleagues can reproduce results exactly under identical conditions.
Verifying Authenticity Before You Run Your Study
Counterfeit compounds damage experiments and waste funding. Therefore, verification should rank among your very first actions upon delivery. Every Dragon Pharma product carries security features that you can cross-check against our database in seconds. Simply enter each lot number on the Product Verification page, and the system confirms whether your units match genuine production runs. Additionally, compare printed certificate-of-analysis values against internal QC thresholds. Should any discrepancy appear, contact us immediately rather than proceeding with the study.
Storage, Shipping, and Handling
Unopened vials stay stable at controlled room temperature, away from direct light and moisture, while tablet packs require the same dry conditions. During transit, we dispatch orders in protective packaging that shields glass from crushing and blisters from heat exposure. Usually, processing completes within one business day, and tracking information follows by email. However, regulations differ between regions; consequently, review your local import rules for investigational compounds before checkout. Transparency here prevents delays and keeps your project moving on schedule.
Important Research-Use Statement
These products serve strictly laboratory and preclinical investigation. They are not FDA-approved medicines for the uses described here, and they do not intend human or veterinary administration. Furthermore, testosterone and stanozolol preparations appear on prohibited-substance lists maintained by major athletic authorities. Qualified personnel should handle all procedures under appropriate institutional protocols and safety equipment.
Order With Confidence
Your procurement team deserves a partner combining traceable sourcing, responsive support, and rigorous documentation across every item in a multi-component stack. To place an order, request pricing, or ask protocol-support questions about the Test Prop + Winstrol Cycle Kit, reach our specialists through the Contact page, and we will reply promptly with stock availability and lot information. Launch your next endocrinology study with material you can trust.




Reviews
There are no reviews yet.